Empirico
Shannon Bruse is a highly experienced individual who has held various scientific roles in companies such as Regeneron Pharmaceuticals, Mirus Bio LLC, and Empirico Inc. Currently, serves as the Cofounder, SVP, and Head of Target Discovery and Biology at Empirico Inc., a venture-backed therapeutics company focused on utilizing biological datasets and genetics for target discovery and development. Prior to this, Bruse held positions such as Associate Director at Regeneron Pharmaceuticals and Senior Scientist at Mirus Bio LLC. Their expertise in translational genetics and scientific operations has been demonstrated through their extensive career history.
This person is not in any teams
Empirico
1 followers
Empirico is a biotechnology company focused on the discovery and development of novel medicines which are designed to mimic naturally-occurring genetic variants that confer beneficial effects on health and disease. Empirico’s two foundational and proprietary technology platforms - the Precision Insights Platform™ for genetically-validated target discovery and siRCH™ for the discovery and development of siRNA medicines - are used separately and in tandem to enable Empirico and our collaborators from the discovery and validation of novel targets to the development of clinically-viable therapeutics. Empirico’s exceptional internal capabilities, augmented by those of its partners, are driving the advancement of a growing and differentiated pipeline of wholly-owned and partnered programs. Empirico is headquartered in San Diego, CA with a major second site in Madison, WI.